The PTP1B selective inhibitor MSI-1436 mitigates Tunicamycin-induced ER stress in human hepatocarcinoma cell line through XBP1 splicing modulation.

Protein tyrosine phosphatase PTP1B is considered as a key metabolic enzyme that has been reported to be associated with insulin resistance onset, and underlying cellular metabolic malfunctions, including ER stress and mitochondrial failure. In this study, effects of selective PTP1B inhibition using...

Full description

Bibliographic Details
Main Authors: Lynda Bourebaba, Sai Santosh Babu Komakula, Christine Weiss, Nabil Adrar, Krzysztof Marycz
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0278566
_version_ 1797943903990579200
author Lynda Bourebaba
Sai Santosh Babu Komakula
Christine Weiss
Nabil Adrar
Krzysztof Marycz
author_facet Lynda Bourebaba
Sai Santosh Babu Komakula
Christine Weiss
Nabil Adrar
Krzysztof Marycz
author_sort Lynda Bourebaba
collection DOAJ
description Protein tyrosine phosphatase PTP1B is considered as a key metabolic enzyme that has been reported to be associated with insulin resistance onset, and underlying cellular metabolic malfunctions, including ER stress and mitochondrial failure. In this study, effects of selective PTP1B inhibition using MSI-1436 on cellular apoptosis, oxidative stress, mitochondrial dysfunction and ER stress have been assessed using an in vitro model of Tunicamycin induced ER stress in HepG2 cell line. Inhibition of PTP1B using MSI-1436 significantly increased cell viability and reduced the number of apoptotic cells as well as the expression of key apoptosis initiators and effectors. MSI-1436 further mitigated ER stress, by downregulating the expression of IRE1, ATF6 and PERK transcripts, all being key ER stress sensors. Interestingly, MSI-1436 inhibited the XBP1 splicing, and thus its UPR-associated transcriptional activity. PTP1B inhibition further enabled to restore proper mitochondrial biogenesis, by improving transmembrane potential, and diminishing intracellular ROS while restoring of endogenous antioxidant enzymes genes expression. PTP1B inhibition using MSI-1436 could improve cellular apoptosis and metabolic integrity through the mitigation of ER and mitochondrial stress signalling pathways, and excessive ROS accumulation. This strategy may be useful for the treatment of metabolic disorders including IR, NAFLD and diabetes.
first_indexed 2024-04-10T20:31:29Z
format Article
id doaj.art-28009dfdd5164ae7b913b4bf372dac26
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-10T20:31:29Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-28009dfdd5164ae7b913b4bf372dac262023-01-25T05:33:23ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01181e027856610.1371/journal.pone.0278566The PTP1B selective inhibitor MSI-1436 mitigates Tunicamycin-induced ER stress in human hepatocarcinoma cell line through XBP1 splicing modulation.Lynda BourebabaSai Santosh Babu KomakulaChristine WeissNabil AdrarKrzysztof MaryczProtein tyrosine phosphatase PTP1B is considered as a key metabolic enzyme that has been reported to be associated with insulin resistance onset, and underlying cellular metabolic malfunctions, including ER stress and mitochondrial failure. In this study, effects of selective PTP1B inhibition using MSI-1436 on cellular apoptosis, oxidative stress, mitochondrial dysfunction and ER stress have been assessed using an in vitro model of Tunicamycin induced ER stress in HepG2 cell line. Inhibition of PTP1B using MSI-1436 significantly increased cell viability and reduced the number of apoptotic cells as well as the expression of key apoptosis initiators and effectors. MSI-1436 further mitigated ER stress, by downregulating the expression of IRE1, ATF6 and PERK transcripts, all being key ER stress sensors. Interestingly, MSI-1436 inhibited the XBP1 splicing, and thus its UPR-associated transcriptional activity. PTP1B inhibition further enabled to restore proper mitochondrial biogenesis, by improving transmembrane potential, and diminishing intracellular ROS while restoring of endogenous antioxidant enzymes genes expression. PTP1B inhibition using MSI-1436 could improve cellular apoptosis and metabolic integrity through the mitigation of ER and mitochondrial stress signalling pathways, and excessive ROS accumulation. This strategy may be useful for the treatment of metabolic disorders including IR, NAFLD and diabetes.https://doi.org/10.1371/journal.pone.0278566
spellingShingle Lynda Bourebaba
Sai Santosh Babu Komakula
Christine Weiss
Nabil Adrar
Krzysztof Marycz
The PTP1B selective inhibitor MSI-1436 mitigates Tunicamycin-induced ER stress in human hepatocarcinoma cell line through XBP1 splicing modulation.
PLoS ONE
title The PTP1B selective inhibitor MSI-1436 mitigates Tunicamycin-induced ER stress in human hepatocarcinoma cell line through XBP1 splicing modulation.
title_full The PTP1B selective inhibitor MSI-1436 mitigates Tunicamycin-induced ER stress in human hepatocarcinoma cell line through XBP1 splicing modulation.
title_fullStr The PTP1B selective inhibitor MSI-1436 mitigates Tunicamycin-induced ER stress in human hepatocarcinoma cell line through XBP1 splicing modulation.
title_full_unstemmed The PTP1B selective inhibitor MSI-1436 mitigates Tunicamycin-induced ER stress in human hepatocarcinoma cell line through XBP1 splicing modulation.
title_short The PTP1B selective inhibitor MSI-1436 mitigates Tunicamycin-induced ER stress in human hepatocarcinoma cell line through XBP1 splicing modulation.
title_sort ptp1b selective inhibitor msi 1436 mitigates tunicamycin induced er stress in human hepatocarcinoma cell line through xbp1 splicing modulation
url https://doi.org/10.1371/journal.pone.0278566
work_keys_str_mv AT lyndabourebaba theptp1bselectiveinhibitormsi1436mitigatestunicamycininducederstressinhumanhepatocarcinomacelllinethroughxbp1splicingmodulation
AT saisantoshbabukomakula theptp1bselectiveinhibitormsi1436mitigatestunicamycininducederstressinhumanhepatocarcinomacelllinethroughxbp1splicingmodulation
AT christineweiss theptp1bselectiveinhibitormsi1436mitigatestunicamycininducederstressinhumanhepatocarcinomacelllinethroughxbp1splicingmodulation
AT nabiladrar theptp1bselectiveinhibitormsi1436mitigatestunicamycininducederstressinhumanhepatocarcinomacelllinethroughxbp1splicingmodulation
AT krzysztofmarycz theptp1bselectiveinhibitormsi1436mitigatestunicamycininducederstressinhumanhepatocarcinomacelllinethroughxbp1splicingmodulation
AT lyndabourebaba ptp1bselectiveinhibitormsi1436mitigatestunicamycininducederstressinhumanhepatocarcinomacelllinethroughxbp1splicingmodulation
AT saisantoshbabukomakula ptp1bselectiveinhibitormsi1436mitigatestunicamycininducederstressinhumanhepatocarcinomacelllinethroughxbp1splicingmodulation
AT christineweiss ptp1bselectiveinhibitormsi1436mitigatestunicamycininducederstressinhumanhepatocarcinomacelllinethroughxbp1splicingmodulation
AT nabiladrar ptp1bselectiveinhibitormsi1436mitigatestunicamycininducederstressinhumanhepatocarcinomacelllinethroughxbp1splicingmodulation
AT krzysztofmarycz ptp1bselectiveinhibitormsi1436mitigatestunicamycininducederstressinhumanhepatocarcinomacelllinethroughxbp1splicingmodulation